# Acta Pharmaceuticals funding rounds and investors

As of 16 Oct 2026, Acta Pharmaceuticals has raised $24M across 1 verified round on record; latest: $24 million seed round, announced 15 Oct 2026.

A provider of therapies designed for early intervention and prevention in Alzheimer’s disease

Website: www.actapharmaceuticals.com  
Headquarters: Boston  
Page: https://fireround.dev/companies/actapharmaceuticals.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-10-15 | Seed | $24 million | not stated | none named | [actapharmaceuticals.com](https://actapharmaceuticals.com/acta-closes-seed-funding-to-advance-alzheimers-program), [businesswire.com](https://www.businesswire.com/news/home/20261015556411/en/Acta-Pharmaceuticals-Closes-%2424-Million-in-Seed-Financing-for-Alzheimers-Disease-Pipeline-Targeting-Early-Intervention-and-Prevention), [biospace.com](https://www.biospace.com/press-releases/acta-pharmaceuticals-closes-24-million-in-seed-financing-for-alzheimers-disease-pipeline-targeting-early-intervention-and-prevention) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.